KRAS and endometrioid adenocarcinoma: Molecular studies indicate that adenomyosis may constitute a clonal disease harboring somatic driver mutations shared with endometrioid carcinoma, including KRAS mutations and alterations in the PI3K-AKT-mTOR signaling pathway.